Loperamide
Therapeutic agent (verify pharmacological class)
What it is used for
Acute diarrhoea in adults and children over 4 years, chronic diarrhoea associated with inflammatory bowel disease, reducing the volume of discharge from ileostomy. Clinical selection for Loperamide should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
If no clinical improvement is observed after 48 hours discontinue its use, hepatic disorders, and careful observation of patients with inflammatory bowel syndrome for signs of toxic megacolon.
Possible side effects
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.